Screening for ovarian cancer. Other malignancies cloud the issue.
作者信息
Clements D
出版信息
BMJ. 1993 Jun 19;306(6893):1685. doi: 10.1136/bmj.306.6893.1685.
Abstract
摘要
相似文献
1
Screening for ovarian cancer. Other malignancies cloud the issue.
BMJ. 1993 Jun 19;306(6893):1685. doi: 10.1136/bmj.306.6893.1685.
2
Screening in ovarian cancer.
Am J Obstet Gynecol. 1991 Jul;165(1):7-10. doi: 10.1016/0002-9378(91)90213-b.
3
Ovarian cancer screening.
Cancer. 1991 Aug 15;68(4):679-80. doi: 10.1002/1097-0142(19910815)68:4<679::aid-cncr2820680402>3.0.co;2-j.
4
Screening for ovarian cancer.
J Am Acad Nurse Pract. 1992 Jan-Mar;4(1):36-7. doi: 10.1111/j.1745-7599.1992.tb01110.x.
5
Screening for ovarian cancer. Still controversial, but encouraging.
BMJ. 1993 Jun 19;306(6893):1684. doi: 10.1136/bmj.306.6893.1684.
6
Screening for ovarian cancer.
BMJ. 1993 Apr 17;306(6884):1015-6. doi: 10.1136/bmj.306.6884.1015.
7
Screening for early ovarian cancer.
Br J Hosp Med. 1992;48(8):454-9.
8
Ovarian cancer screening: new trial tries new twists.
J Natl Cancer Inst. 1995 Sep 6;87(17):1283-5. doi: 10.1093/jnci/87.17.1283.
9
Ovarian cancer screening.
Curr Opin Obstet Gynecol. 1994 Feb;6(1):67-74.
10
CA-125 as a screening test for ovarian cancer.
JAMA. 1993;269(24):3106-7.
本文引用的文献
1
Prevalence screening for ovarian cancer in postmenopausal women by CA 125 measurement and ultrasonography.
BMJ. 1993 Apr 17;306(6884):1030-4. doi: 10.1136/bmj.306.6884.1030.
2
Tumour marker antigen CA125 in pancreatic cancer: a comparison with CA19-9 and CEA.
Br J Cancer. 1986 Dec;54(6):897-901. doi: 10.1038/bjc.1986.259.
Zotero 插件